- Anti‐spasticity agents for multiple sclerosis
- Antistreptococcal interventions for guttate and chronic plaque psoriasis
- Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery
- Antithrombotic drugs for carotid artery dissection
- Anti‐tuberculous therapy for maintenance of remission in Crohn's disease
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
- Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis
- Anxiolytics for smoking cessation
- Aripiprazole for schizophrenia
- Aripiprazole versus typical antipsychotic drugs for schizophrenia
- Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women
- Artemether-lumefantrine for treating uncomplicated falciparum malaria
- Aspirin for in vitro fertilisation
- Atypical antipsychotics for aggression and psychosis in Alzheimer's disease
- Atypical antipsychotics for people with both schizophrenia and depression
- Azathioprine for multiple sclerosis
- Azithromycin for acute lower respiratory tract infections
- Azoles for allergic bronchopulmonary aspergillosis associated with asthma
- Beclomethasone for asthma in children: effects on linear growth
- Behavioural and cognitive interventions with or without other treatments for the management of faecal incontinence in children
The Cochrane Database of Systematic Reviews is considered the gold standard for evidence-based medicine. Essential Evidence Plus includes the latest and most up-to-date summaries of systematic reviews from the Cochrane Library, which are the most rigorous and reliable evaluations of medical therapies available. You’ll find summarized evaluations of the world’s best literature on the effectiveness of therapy for 3,300+ clinical problems.